| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 56.32B | 63.03B | 54.38B | 55.05B | 68.26B | 62.28B |
| Gross Profit | 17.56B | 20.20B | 17.12B | 18.00B | 24.48B | 19.34B |
| EBITDA | 5.09B | 4.10B | 4.83B | 6.49B | 12.88B | 9.78B |
| Net Income | 1.65B | 4.07B | 978.00M | 2.67B | 7.47B | 4.13B |
Balance Sheet | ||||||
| Total Assets | 120.52B | 125.46B | 120.67B | 119.19B | 114.35B | 107.08B |
| Cash, Cash Equivalents and Short-Term Investments | 24.17B | 25.00B | 24.43B | 19.77B | 18.85B | 18.00B |
| Total Debt | 31.96B | 30.54B | 34.90B | 32.71B | 22.12B | 23.86B |
| Total Liabilities | 44.20B | 42.27B | 45.03B | 43.02B | 42.68B | 43.10B |
| Stockholders Equity | 76.32B | 83.18B | 75.63B | 76.16B | 71.66B | 63.97B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.22B | 3.27B | -6.79B | 4.21B | 8.47B |
| Operating Cash Flow | 0.00 | 9.48B | 6.45B | -2.49B | 6.40B | 10.27B |
| Investing Cash Flow | 0.00 | -3.73B | -3.44B | -5.30B | -2.70B | -2.10B |
| Financing Cash Flow | 0.00 | -6.20B | 912.00M | 7.57B | -3.35B | -6.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥939.07B | 10.13 | 9.10% | 1.63% | 9.80% | 13.15% | |
78 Outperform | ¥101.42B | 9.96 | ― | 3.85% | 19.61% | 25.91% | |
74 Outperform | ¥323.91B | 11.92 | 7.86% | 2.55% | 5.68% | 41.20% | |
71 Outperform | ¥157.17B | 14.58 | ― | 2.82% | 15.90% | 313.65% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥140.57B | 26.06 | 2.64% | 2.30% | 0.90% | 15.74% | |
60 Neutral | ¥250.88B | 13.65 | -4.83% | 3.08% | 0.09% | ― |